Navigation Links
Matthew Sarad to Reverse Aging and Cure Cancer
Date:9/11/2009

gene carriers capable of replacing damaged mitochondrial DNA
  • License or invent the in vivo delivery of tumor suppressor proteins that are potentially safer and more efficacious in the treatment of cancer
  • License and improve the in vivo delivery of a variety of age-related proteins such as SOD and catalase in the treatment of disease
  • Build a large-scale manufacturing plant and commercial laboratory for studying and producing biodegradable nanoparticles

  • "The only way I understand how to make people, including regulators, fully appreciate the value of the technologies I have been working on for the past 10 years is to make a public and visible attempt at rejuvenating an animal. This was the central goal of my company when I founded it. I hope in so doing to rehabilitate my reputation, fix my former company, and bring important medical technologies to global pharmaceutical markets. Those who wish to help may visit MatthewSarad.com and read about this not-for-profit project."

    The project goal is to produce and administer a variety of nanotechnology based therapeutics in sheep. Sheep are the ideal animal to study because their DNA is similar to human DNA and human telomerase is effective in lengthening their telomeres. In addition to telomere lengthening the sheep will receive other nanotechnology based therapeutics designed to cause rejuvenation. If successful this experiment might inspire even more elaborate and powerful future experiments. It might also attract interest and money into the field which can be used to tackle some extremely serious and crippling degenerative diseases including cancer.

    ###

    Read the full story at http://www.prweb.com/releases/2009/09/prweb2840554.htm.


    '/>"/>
    Source: PRWeb
    Copyright©2009 Vocus, Inc.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
    2. Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
    3. Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greeces Leading Biotech Magazine
    4. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
    5. Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer
    6. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
    7. Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined
    8. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
    9. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
    10. USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration
    11. Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)...  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... and difficult to manufacture proteins including biosimilar therapeutics, ... results for the second quarter ended June 30, ... our initial public offering, we have the capital ... derived from our proprietary protein expression platform," stated ...
    (Date:8/29/2014)... on electrons, but one of the most promising technologies ... based on light (photons) instead of electrons. First, it ... of single photons and control their direction. Researchers around ... achieve this control, but now scientists at the Niels ... of photons emitted one at a time and in ...
    (Date:8/29/2014)... York (PRWEB) August 29, 2014 ... at $5.6 billion in 2019. It is expected ... 2013 to 2019, and was valued at $1.8 ... published by Transparency Market Research. , For more ... http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research report, titled ...
    (Date:8/29/2014)... Albany, New York (PRWEB) August 29, 2014 ... Research “Global Orthobiologics Market” the global orthobiologics market was valued ... reach a market worth USD 5,519.9million in 2019at a CAGR ... the population aged 50 years and above is afflicted by ... almost double by the year 2020. This has and will ...
    Breaking Biology Technology:Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8Breakthrough in light sources for new quantum technology 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3
    ... SAN FRANCISCO, March 16 Medivation, Inc. (Nasdaq: ... and financial results for the fourth quarter and year ended December ... to an equally exciting 2009. We have made excellent progress across ... testing in all of our programs in 2009 -- Dimebon in ...
    ... 16 TauTaTis, Inc. announces that its lead compound ... process in Alzheimer,s Disease, has been recognized as the ... Disease gene LRRK2 reported to date. Mutations of ... are the most genetic frequent cause of Parkinson,s Disease.TauTaTis, ...
    ... Provider, Offers Traceability Down to the Unit Level to Secure ... ... Southborough, MA (PRWEB) March 16, 2009 -- PHARMORX ... technology services provider, today announced the availability of its new ...
    Cached Biology Technology:Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 2Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 3Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 4Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 5Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 6Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 7Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 8TauTaTis Discovers Potent Inhibitor of Parkinson's Disease Gene Activity 2PHARMORX Security Introduces New Technology Solutions for Counterfeiting, Grey Market Diversion, Track & Trace 2PHARMORX Security Introduces New Technology Solutions for Counterfeiting, Grey Market Diversion, Track & Trace 3
    (Date:8/29/2014)... Davis have made some surprising discoveries about the ... immunodeficiency virus (SIV), the team found that specialized ... early responders to viral invasion and are the ... called interleukin-1 beta (IL-1β). , Though aimed ... of the gut epithelium that provides a barrier ...
    (Date:8/29/2014)... Scientists at the Barshop Institute for Longevity and ... the UT Health Science Center at San Antonio, have ... the longest-lived rodent, the naked mole rat. , ... naked mole rats protects and alters the activity of ... proteins. , The factor also protects proteasome function in ...
    (Date:8/29/2014)... about what genetic changes transform wild animals into domesticated ... is a University of Montana assistant professor, has made ... of the brain and the nervous system were particularly ... 28 in Science and gives answers to ... ., The domestication of animals and plants, a prerequisite ...
    Breaking Biology News(10 mins):The early cost of HIV 2Factor in naked mole rat's cells enhances protein integrity 2New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3
    ... of the University of New Hampshire campus, David Berlinsky, assistant ... Inside, black sea bass circle slowly in the dim light. ... the College of Life Sciences and Agriculture, and home to ... many menus, but wild populations of the fish are in ...
    ... with hepatitis C virus (HCV) achieved significantly better ... Cyclosporine along with interferon-ribavirin combination therapy. Cyclosporine also ... , The results of this study appear ... the official journal of the American Association for ...
    ... infants born with HIV infection may be most effective ... according to a study published in the April 1 ... online. , Uncertainty over when to start antiretroviral treatment ... around balancing the benefits of preventing disease progression and ...
    Cached Biology News:Uncovering sex-change secrets of black sea bass 2Cyclosporine inhibits hepatitis C virus in vitro 2New study shows benefit of early therapy in HIV-infected infants 2
    ... Ideal for staining westerns and includes stickers ... Pour spouts in each corner facilitate pouring ... be used for identification. Lid is designed ... for staining several gels simultaneously. Lid also ...
    ID clarifier: non-treated with lid...
    ... Staccato Series of systems provide fast and reliable scalable ... drug development laboratories. Staccato systems are available in three ... Systems Series. ... All Staccato ...
    ... Staccato Custom Series Systems provide ... drug discovery, genomics, proteomics and drug ... built specifically to customer specifications, providing ... individual needs. Staccato Custom Systems ...
    Biology Products: